Director, Clinical Development

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

Requirements

• PhD, PharmD or equivalent is required.
• Minimum 8+ years of experience in the pharmaceutical or biotechnology industry as a clinical scientist or related role.
• Proven leadership in a collaborative team setting and driven by a desire to deploy innovative approaches and technologies in a high-energy environment.
• Detail-oriented with ability prioritize tasks and function independently as appropriate.
• Strong organizational skills and an ability to interpret, discuss, and report trial/program level data effectively and identify trends.
• Proficient with software tools (Microsoft Office), Electronic Data Capture, and other custom web-based software.
• Excellent written and verbal communication skills.

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities